Reproducible measurable residual disease detection by multiparametric flow cytometry in acute myeloid leukemia

HIGHLIGHTS

• who: Maximilian A. Ru00f6hnert from the All leukemia-free controls (LFC, n=90) were treated at the University Hospital Dresden (Supplementary Table, ) and analyzed by three independent investigatorsThe aberrant subpopulations as described below (n=32) were also observed in LFC with different frequencies. The upper limit of the one-sided, .5% reference range for the percentage of each aberrant population among CD45+ events was set as reference value. LFC included BM aspirates of BM donors (n=30), of patients with acute lymphoblastic leukemia in molecular CR (ALL molCR) (n=19) with a prior exposure to chemotherapy (median . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.